Jason Politi
Directeur Technique/Scientifique/R&D chez VERVE THERAPEUTICS, INC.
Provenance du réseau au premier degré de Jason Politi
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 28 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jason Politi via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal | |
| DYAX CORP. | Pharmaceuticals: Major | Chief Administrative Officer Chief Tech/Sci/R&D Officer Chief Administrative Officer Investor Relations Contact Chief Tech/Sci/R&D Officer | |
iBASIS, Inc.
 iBASIS, Inc. Specialty TelecommunicationsCommunications iBasis, Inc. provides international voice carrier and value added services for mobile operators. It offers comprehensive portfolio of voice termination and data services, including messaging, signaling and roaming, and mobile operators, as well as voice-over-broadband service providers. The company was founded in 1996 and is headquartered in Lexington, MA. | Specialty Telecommunications | Corporate Officer/Principal | |
Digitas, Inc.
 Digitas, Inc. Miscellaneous Commercial ServicesCommercial Services Digitas, Inc. provides digital and interactive marketing services to the Internet-based and e-commerce companies. The company also provides cross-channel communications to clients. Its services include customer acquisition, cross-sell, loyalty, affinity and customer care operations. The company was founded by Robert L. Cosinuk in 1999 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| George Washington University Law School | College/University | Graduate Degree Graduate Degree | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact Director/Board Member | |
GV Management Co. LLC
 GV Management Co. LLC Investment ManagersFinance GV Management Co LLC (Google Ventures) is a venture capital firm, a subsidiary of Google LLC founded in 2009 by Bill Maris. The firm is headquartered in Mountain View, California with an additional office in San Francisco, Boston, New York and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Spotlight Therapeutics, Inc. engages in gene editing therapeutics. It focused in reprogramming tumor microenvironment. The company was founded by Alex Marson, Patrick Hsu, and Jacob Corn in 2017 and is headquartered in Hayward, CA. | Pharmaceuticals: Generic | Director/Board Member Chief Tech/Sci/R&D Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Masters Business Admin | |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| AEROVATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| LYRA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree | |
| University of Cincinnati (Ohio) | College/University | Doctorate Degree | |
| RHYTHM PHARMACEUTICALS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Allergan GI Corp.
 Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Foresite Capital Management LLC
 Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco. | Investment Managers | Consultant / Advisor | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| VOYAGER THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Rare-X
 Rare-X Packaged SoftwareTechnology Services Part of Global Genes, Rare-X is a patient advocacy organization based in Washington. Rare-X is focused on supporting the acceleration and development of life-altering treatments and future cures for patients impacted by a rare disease. Rare-X is building the largest collaborative patient-driven, open-data access project for rare diseases ly, gathering structured, fit-for-purpose data to share broadly, benefitting from 21st-century governance, consent, and federated data sharing technology. Rare-X's goal is to build the largest collaborative patient-driven, open-data access project for rare diseases ly. The American company was founded in 2019 by Nicole Boice. The CEO is Charlene Son Rigby. Rare-X was acquired by Global Genes on February 07, 2023. | Packaged Software | Director/Board Member | |
| Suffolk University | College/University | Graduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Regis University | College/University | Graduate Degree | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor | |
| BEAM THERAPEUTICS INC. | Biotechnology | Chief Executive Officer | |
| PRIME MEDICINE, INC. | Biotechnology | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| INSULET CORPORATION | Medical Specialties | Director of Finance/CFO | |
Orbital Therapeutics, Inc.
 Orbital Therapeutics, Inc. BiotechnologyHealth Technology Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation. | Biotechnology | Director/Board Member | |
| DECIPHERA PHARMACEUTICALS, INC. | Biotechnology | Investor Relations Contact | |
| Dartmouth College | College/University | Undergraduate Degree | |
| University of Rhode Island | College/University | Undergraduate Degree | |
| University of Vermont | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 50 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 14 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 56 |
| Corporate Officer/Principal | 50 |
| Undergraduate Degree | 25 |
| Chief Tech/Sci/R&D Officer | 17 |
| Founder | 15 |
Relations les plus connectées
| Insiders | |
|---|---|
| Krishna Yeshwant | 25 |
| Burt Adelman | 23 |
| Sheila Mikhail | 22 |
| John Evans | 12 |
| Allison Dorval | 12 |
| Michael MacLean | 11 |
| Fred Fiedorek | 8 |
| Alexander Cumbo | 8 |
| Lonnel Coats | 8 |
| Sekar Kathiresan | 8 |
| Yasser El-Gamal | 7 |
| Andrew Bellinger | 7 |
| Andrew Ashe | 7 |
| Anthony Philippakis | 7 |
| Ellen Rohde | 6 |
- Bourse
- Insiders
- Jason Politi
- Connexions Sociétés
